Tiffany Olson

This profile gathers the share dealings of Tiffany Olson across 3 companies, led by Castle Biosciences Inc, Biotelemetry, Inc. and Mimedx Group, Inc. The record holds 16 filings, for trades running from 3 May 2019 to 22 May 2026.

Purchases make up the whole of the open-market record (3 purchases, €48k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants and 8 option exercises.

Half of the purchases are above €20k and half below. Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The newest entry dates from 27 May 2026: an option exercise, in Castle Biosciences Inc. The clock since the last published purchase (1 December 2022) now reads 1,423 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.